임프리메드 연구/논문

임프리메드의 연구 결과를 읽어보세요.

Human Precision Medicine

Research article titled 'Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning' with abstract and introduction sections explaining study purpose, methods, results, and conclusion on chemotherapy regimen optimization.

Published in Biotechnology and Bioprocess Engineering, Jan 2026

Quantitative ex vivo assessment of chemotherapy synergy using patient-derived non-Hodgkin lymphoma samples

논문 보기
Title and abstract of a scientific study on predicting chemotherapy response in advanced pancreatic cancer patients using machine learning models.

Published in JCO Clinical Cancer Informatics, Dec 2025

Predicting Chemotherapy Response in Patients With Advanced or Metastatic Pancreatic Cancer Using Machine Learning

논문 보기
First page of a scientific article from Frontiers in Immunology titled 'Machine learning-based prediction of response to Janus kinase inhibitors in patients with rheumatoid arthritis using clinical data', including authors, affiliations, and an abstract summary.

Published in Frontiers in Immunology, Nov 2025

Machine learning-based prediction of response to Janus kinase inhibitors in patients with rheumatoid arthritis using clinical data

논문 보기

Published in Blood Research, Nov 2024

Recent advances in and applications of ex vivo drug sensitivity analysis for blood cancers

논문 보기

Poster abstract presented in The 65th ASH Annual Meeting, Nov 2023

Prognostic Utility of the Patient-Derived AML Cells' Ex Vivo Drug Sensitivity Results

논문 보기
First page of Prognostic value of European Leukemia Net 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia, published Sept 2023

Published in Haematologica, Sept 2023

Prognostic value of European Leukemia Net 2022 criteria and genomic clusters using machine learning in older adults with acute myeloid leukemia

논문 보기
ImpriMed's article on "ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma" was published in npj precision oncology

Published in npj Precision Oncology, May 2023

ML-based sequential analysis to assist selection between VMP and RD for newly diagnosed multiple myeloma

논문 보기

임프리메드 코리아에 대해 더 궁금하신가요?
언제든지 연락주세요.